About
MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.
- Name
- YieldMax MRNA Option Income Strategy ETF
- Index tracked
- S&P 500 (TR) (1970)
- Type
- Equity
- Expense ratio
- 1%
- Management fee
- 0.99%
- Dividend policy
- Weekly
- NAV
- USD 32.5214 (09/15/2026)
- Issued units
- 4.35M (09/15/2026)
- Listing date
- Oct 23, 2023
- Sponsor
- YieldMax ETFs
- Custodian
- U.S. Bank NA